Sustained high expression of NRF2 inhibits cell apoptosis in arsenite-transformed human keratinocytes

Qianlei Yang1, Ting Zhang1, Jian Liu2

  • 1Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.

Insights

Arsenite exposure activates nuclear factor-erythroid-2 p45-related factor 2 (NRF2), reducing apoptosis and promoting skin cancer. Silencing NRF2 reversed these effects, highlighting NRF2

Area of Science:

  • Oncology
  • Molecular Biology
  • Toxicology

Background:

  • Nuclear factor-erythroid-2 p45-related factor 2 (NRF2) is activated in arsenite-induced tumorigenesis.
  • Mechanisms of NRF2 in arsenic-induced skin carcinogenesis apoptosis remain unclear.

Purpose of the Study:

  • Investigate NRF2's role in apoptosis during arsenite-induced HaCaT cell malignant transformation.
  • Explore dynamic changes in apoptosis and related proteins.

Main Methods:

  • Cultured immortalized human keratinocytes (HaCaT) with 1.0 μM NaAsO2 across multiple passages.
  • Assessed apoptosis rates and protein expression (caspase-3, CHOP, ATF4, ATF6, Bax, Bcl-2, Mcl-1, NRF2).
  • Silenced NRF2 in arsenite-transformed HaCaT (T-HaCaT) cells to evaluate apoptosis and cellular functions.

Main Results:

  • Apoptosis rate and cleaved-caspase-3/caspase-3 ratio decreased in later passages.
  • NRF2, Bcl-2, and Mcl-1 levels increased, while CHOP, ATF4, ATF6, and Bax decreased.
  • NRF2 silencing increased apoptosis, decreased colony formation/migration, and upregulated pro-apoptotic proteins.

Conclusions:

  • Arsenite activates NRF2 in later stages, inhibiting ER and mitochondrial apoptosis pathways.
  • NRF2 promotes arsenite-induced HaCaT cell malignant transformation by reducing apoptosis.
  • Targeting NRF2 may offer therapeutic strategies for arsenic-induced skin carcinogenesis.